• FDA eyes major vaccine strategy changes: 3 COVID-19 updates

    The FDA is considering a new COVID-19 vaccination strategy that would mirror the process for creating and administering annual flu shots, federal documents show.
  • As XBB.1.5's prevalence grows, COVID-19 activity falls: 7 updates

    COVID-19 cases, hospitalizations and deaths fell nationwide this week, even as the highly transmissible omicron subvariant XBB.1.5 grew to account for about half of all U.S. infections, according to the CDC's COVID-19 data tracker weekly review published Jan. 20. 
  • How flu cases compare to past seasons

    The U.S. may see a higher amount of flu cases this season compared to past years, preliminary CDC estimates suggest. 
  • Most states now report low, minimal flu activity: 5 FluView notes

    No state or region in the U.S. saw "very high" levels of flu activity for the week ending Jan. 14, the CDC's latest FluView report shows. Not since October has no state reported very high flu activity. 
  • American Heart Association issues new guidelines for diagnosing 'warning strokes' in ER

    Patients who present in the emergency room with signs of a possible transient ischemic attack require in-depth evaluation even if symptoms are no longer present, according to new guidelines issued by the American Heart Association.
  • Health officials probe 1st cases of new drug-resistant gonorrhea strain in Massachusetts

    A unique strain of gonorrhea identified in two residents in Massachusetts showed little or no response to five classes of antibiotics, health officials said Jan. 19.
  • COVID-19 admissions dip: Where they're lowest, falling fastest

    COVID-19 hospitalizations are declining nationwide even as the highly transmissible omicron subvariant XBB.1.5 gains prevalence. 
  • The discrepancies behind recent COVID-19 hospitalization, death data

    Holiday disruptions are likely behind discrepancies in COVID-19 data that have emerged in the last few weeks, according to health experts. The nation's daily average for hospitalizations has fallen by about 15 percent over the last two weeks, data from The New York Times shows. Meanwhile, data also suggests COVID-19 deaths have risen within the same time frame.
  • St. Louis Children's hospital saw 50% rise in patients with gun injuries amid pandemic

    In the first two years of the pandemic, St. Louis Children's Hospital saw the average number of children and teens needing treatment for gunshot wounds increase by 50 percent, St. Louis Public Radio reported Jan. 18. 
  • HHS' oversight of pathogen research is lacking, report finds

    HHS does not have a strong framework in place to adequately monitor research involving potential pandemic pathogens, the U.S. Government Accountability Office said in a Jan. 18 report. 
  • Hybrid immunity offers one year of protection against COVID-19 recurrence: Study

    Hybrid immunity, the combination of COVID-19 recovery and immunization, provides up to 12 months of protection against severe reinfection or hospitalization, according to a study published in The Lancet on Jan. 18. 
  • 'Tripledemic' has peaked, CDC data suggests

    The weekly rate of emergency department visits and hospitalizations for flu, COVID-19 and respiratory syncytial virus peaked in early December, new CDC data shows. 
  • Proportion of Americans delaying medical care over cost hits a high: Gallup

    Thirty-eight percent of Americans said they put off medical treatment in 2022 because of the cost, according to a Gallup poll published Jan. 17. This marks a 12 percentage point increase from those who said the same a year earlier, and the highest since Gallup began tracking the question in 2001. 
  • COVID-19 admissions dip as XBB.1.5 spreads 

    Although the highly transmissible omicron subvariant XBB.1.5 is gaining prevalence nationwide, COVID-19 cases are flat and hospitalizations have dipped. The data suggests the U.S. will see more of a COVID-19 "bump" this winter versus a full-fledged surge, according to The New York Times.
  • Flu positivity drops: 6 FluView notes

    Of more than 96,000 specimens tested for influenza at U.S. clinical laboratories for the week ending Jan. 7, 8.6 percent were positive, the CDC's latest FluView report shows. This figure hovered around 25 percent for several consecutive weeks in December. 
  • XBB.1.5 rises to 43% of cases: 4 COVID-19 updates

    In about a week, the prevalence of omicron subvariant XBB.1.5 grew more than 50 percent, according to the latest CDC variant proportion estimates.
  • When will long COVID-19 symptoms ease? New study offers clues

    Most long COVID-19 symptoms among people who had a mild infection ease within a year, according to findings published Jan. 11 in The BMJ. 
  • Childhood vaccination rates fall for 2nd year

    Routine childhood vaccinations fell nationwide during the 2021-22 school year and sat below target levels for the second consecutive year, the CDC reported Jan. 12.
  • Why XBB.1.5 will not get a Greek letter: WHO

    The XBB.1.5 omicron subvariant does not warrant its own Greek letter name — at least not yet — because data suggests it is behaving similarly to other omicron sublineages in terms of transmissibility, severity, immune escape and its effect on interventions, according to the World Health Organization. 
  • Ebola outbreak is over: WHO

    Uganda officials declared the end of the Ebola outbreak less than four months after the first case was confirmed, the World Health Organization said Jan. 11.

Featured Whitepapers

Featured Webinars